Abstract
Rationale
Motor dysfunctions might be a more common side effect of serotonergic than noradrenergic antidepressants. However, the effects of antidepressants on motor function in depression have rarely been analyzed systematically. Computerized methods allow the objective registration of drug-induced motor dysfunction and were applied in this study.
Objectives
To examine the effects of a selective noradrenaline re-uptake inhibitor (NARI) (reboxetine) and a selective serotonin re-uptake inhibitor (SSRI) (citalopram) on hand-motor function in patients with major depression.
Methods
Different types of hand movements (drawing of circles and handwriting probes) were recorded and analyzed in 16 acutely depressed inpatients receiving citalopram (30–60 mg/day) and 12 acutely depressed inpatients treated with reboxetine (4–8 mg/day), using a digitizing tablet for the analysis of movement dynamics. Both groups were comparable regarding mean age (42–43 years), gender, handedness (preponderance of right-handers) and the mean baseline HAMD score (about 27). Five kinematical parameters reflecting velocity, regularity and degree of automation of hand movements have been computed.
Results
Reboxetine had significantly more favorable effects on fine motor function (increased velocity of rapid hand movements) in depressed patients than citalopram. These differences became obvious when patients conducted more complex tasks and are not explained by differential antidepressant effects.
Conclusions
Our findings are in line with the hypothesis that SSRI tend to have small, but more pronounced negative effects on motor function than NARI.
Similar content being viewed by others
References
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington D.C.
Box GEP (1954) Some theorems on quadratic forms applied in the study of analysis of variance problems. II. Effects of inequality of variance and of correlation between errors in the two-way classification. Ann Math Stat 25:484–498
Caligiuri MP, Ellwanger J (2000) Motor and cognitive aspects of motor retardation in depression. J Affect Disord 57:83–93
Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454
Dilling H, Mombour W, Schmidt MH (1992) World Health Organization: ICD-10 Kapitel V (F). Internationale Klassifikation psychischer Störungen. Huber, Göttingen
Ferguson JM, Mendels J, Schwart GE (2002) Effects of reboxetine on Hamilton depression rating scale factors from randomized, placebo-controlled trials in major depression. Int Clin Psychopharmacol 17:45–51
Fleminger S (1992) Control of simultaneous movements distinguishes depressive motor retardation from Parkinson’s disease and neuroleptic parkinsonism. Brain 115:1459–1480
Gony M, Lapeyre-Mestre M, Montastruc JL, French Network of Regional Pharmacovigilance Centers (2003) Risk of serious extrapyramidal symptoms in patients with Parkinson’s disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs. Clin Neuropharmacol 26:142–145
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Henkel V, Mergl R, Juckel G, Rujescu D, Mavrogiorgou P, Giegling I, Möller H-J, Hegerl U (2001) Assessment of handedness using a digitizing tablet: a new method. Neuropsychologia 39:1158–1166
Hindmarch I (1997) The effects of antidepressants on psychomotor function with particular reference to reboxetine. Eur Neuropsychopharmacol 7(Suppl 1):S17–S21
Kerr JS, Powell J, Hindmarch I (1996) The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol 42:239–241
Lader M, Melhuish A, Frcka G, Fredricson Overo K, Christensen V (1986) The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur J Clin Pharmacol 31:183–190
Lane RM (1998) SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol 12:192–214
Lemelin S, Baruch P (1998) Clinical psychomotor retardation and attention in depression. J Psychiatr Res 32:81–88
Lemke MR (2002) Effect of reboxetine on depression in Parkinson’s disease patients. J Clin Psychiatry 63:300–304
Linazasoro G (2000) Worsening of Parkinson’s disease by citalopram. Parkinsonism Relat Disord 6:111–113
Mai N, Marquardt C (1992) CS—Computerunterstützte Analyse der Bewegungsabläufe beim Schreiben. Bedienungshandbuch. MedCom, München
Marquardt C, Mai N (1994) A computational procedure for movement analysis in handwriting. J Neurosci Methods 52:39–45
Mergl R, Tigges P, Schröter A, Möller H-J, Hegerl U (1999) Digitized analysis of handwriting and drawing movements in healthy subjects: methods, results and perspectives. J Neurosci Methods 90:157–169
Mergl R, Juckel G, Rihl J, Karner M, Tigges P, Schröter A, Hegerl U (2004) Kinematical analysis of handwriting movements in depressed patients. Acta Psychiatr Scand 109:383–391
Meulenbroek RGJ, van Galen GP (1988) The acquisition of skilled handwriting: discontinuous trends in kinematic variables. In: Colley A, Beech J (eds) Cognition and action in skilled behaviour. Elsevier, Amsterdam, pp 273–281
Milne JR, Goa KL (1991) Citalopram. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs 41:450–477
Muldoon C (1996) The safety and tolerability of citalopram. Int Clin Psychopharmacol 11(Suppl 1):35–40
Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 9:97–113
Parkinson Study Group Richard ICH, Kurlan R (1997) A survey of antidepressant drug use in Parkinson’s disease. Neurology 49:1168–1170
Sabbe B, van Hoof JJM, Hulstijn W, Zitman FG (1996) Changes in fine motor retardation in depressed patients treated with fluoxetine. J Affect Disord 40:149–157
Sabbe B, van Hoof JJM, Hulstijn W, Zitman FG (1997) Depressive retardation and treatment with fluoxetine: assessment of the motor component. J Affect Disord 43:53–62
Sabbe B, Hulstijn W, van Hoof JJM, Tuynman-Qua HG, Zitman F (1999) Retardation in depression: assessment by means of simple motor tasks. J Affect Disord 55:39–44
Sachdev P, Aniss AM (1994) Slowness of movement in melancholic depression. Biol Psychiatry 34:253–262
Siepmann M, Muck-Weymann M, Joraschky P, Kirch W (2001) The effects of reboxetine on autonomic and cognitive functions in healthy volunteers. Psychopharmacology 157:202–207
Thomassen AJWM, van Galen GP (1992) Handwriting as a motor task: experimentation, modelling, and simulation. In: Summers JJ (ed) Approaches to the study of motor control and learning. Elsevier, Amsterdam, pp 113–144
Tucha O, Aschenbrenner S, Eichhammer P, Putzhammer A, Sartor H, Klein HE, Lange KW (2002) The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression. Psychopharmacology 159:211–215
Tucker DM, Williamson PA (1984) Asymmetric neural control systems in human self-regulation. Psychol Rev 91:185–215
Volz H-P, Steil R, Kriese B, Kimmel M, Sauer H, Schüler P, Straube ER (2000) Effekte von Reboxetin und Paroxetin im Vergleich zu Placebo auf kognitive Prozesse bei Gesunden. Nervenarzt 71(Suppl 1):S139
World Health Organization (WHO) (1992) International statistical classification of diseases and related health problems (ICD-10). Chapter V. Mental and behavioral disorders. Diagnostic guidelines. World Health Organization, Geneva
Yamato H, Kannari K, Shen H, Suda T, Matsunaga M (2001) Fluoxetine reduces l-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum. Neuroreport 12:1123–1126
Acknowledgements
We thank the patients for their readiness to participate in our study. This project was partly supported by the German Ministry for Education and Research within the promotional emphasis “German Network on Depression” (Subproject 6.3) and Pharmacia Upjohn, Inc., Germany. The experiment complies with the current laws of the country in which it was performed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hegerl, U., Mergl, R., Henkel, V. et al. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression. Psychopharmacology 178, 58–66 (2005). https://doi.org/10.1007/s00213-004-1983-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-004-1983-7